SCHOFIELD, Wis., May 13, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic™, announced today that it will host a shareholder conference call on Tuesday, May 18, 2010, at 4:10 p.m. EDT (3:10 p.m. CDT) to discuss quarterly earnings and to provide a corporate update. The call will begin with a 15-minute presentation followed by a Q&A session.
